Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up
Open accessAbstract
COVID-19 outbreak is associated with mental health implications during viral infection and at short-term follow-up. Data on psychiatric and cognitive sequelae at medium-term follow-up are still lacking. During an ongoing prospective cohort study, the psychopathological and cognitive status of 226 COVID-19 pneumonia survivors (149 male, mean age 58) were prospectively evaluated one and three months after hospital discharge. Psychiatric clinical interview, self-report questionnaires, and neuropsychological profiling of verbal memory, working memory, psychomotor coordination, executive functions, attention and information processing, and verbal fluency were performed. Three months after discharge from the hospital, 35.8% still self-rated symptoms in the clinical range in at least one psychopathological dimension. We observed persistent depressive symptomatology, while PTSD, anxiety, and insomnia decreased during follow-up. Sex, previous psychiatric history, and the presence of depression at one month affected the depressive symptomatology at three months. Regardless of clinical physical severity, 78% of the sample showed poor performances in at least one cognitive domain, with executive functions and psychomotor coordination being impaired in 50% and 57% of the sample. Baseline systemic immune-inflammation index (SII), which reflects the immune response and systemic inflammation based on peripheral lymphocyte, neutrophil, and platelet counts, predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up; and changes of SII predicted changes of depression during follow-up. Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII. We hypothesize that COVID-19 could result in prolonged systemic inflammation that predisposes patients to persistent depression and associated neurocognitive dysfunction. The linkage between inflammation, depression, and neurocognition in patients with COVID-19 should be investigated in long-term longitudinal studies, to better personalize treatment options for COVID-19 survivors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 65 cited sources checked · 0 supported · 0 flagged
- Findingown data
Insomnia symptoms decreased significantly from one to three months after discharge.
“We observed persistent depressive symptomatology, while PTSD, anxiety, and insomnia decreased during follow-up.”
- Also stated in: § Psychopathology and need for treatment · plain
“From the one-month to the three-month follow-up, patients showed a significant decrease over time of PTSD symptoms (IES-R: F = 21.29, p = 0.001; PCL-5: F = 9.07, p = 0.003), anxiety (STAI-state: F = 11.28, p = 0.001), and insomnia (WHIIRS: F = 9.36, p = 0.003), irrespectively of sex and previous psychiatric history”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
Obsessive-compulsive symptoms worsened significantly from one to three months after discharge.
“In contrast, depression (according to ZSDS and BDI) did not significantly change; and obsessive–compulsive symptomatology significantly worsened (F = 4.84, p = 0.030) with no effect of sex and psychiatric history”
Quote in the paperSubstantial claim - Findingown data
PTSD symptoms decreased significantly from one to three months after discharge.
“We observed persistent depressive symptomatology, while PTSD, anxiety, and insomnia decreased during follow-up.”
- Also stated in: § Psychopathology and need for treatment · plain
“From the one-month to the three-month follow-up, patients showed a significant decrease over time of PTSD symptoms (IES-R: F = 21.29, p = 0.001; PCL-5: F = 9.07, p = 0.003)”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
Anxiety symptoms decreased significantly from one to three months after discharge.
“We observed persistent depressive symptomatology, while PTSD, anxiety, and insomnia decreased during follow-up.”
- Also stated in: § Psychopathology and need for treatment · plain
“From the one-month to the three-month follow-up, patients showed a significant decrease over time of PTSD symptoms (IES-R: F = 21.29, p = 0.001; PCL-5: F = 9.07, p = 0.003), anxiety (STAI-state: F = 11.28, p = 0.001), and insomnia (WHIIRS: F = 9.36, p = 0.003), irrespectively of sex and previous psychiatric history”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
Depressive symptoms did not change significantly between one and three months after discharge.
“In contrast, depression (according to ZSDS and BDI) did not significantly change”
Quote in the paperSubstantial claim
- Findingown data
At three months after discharge, 35.8% of the 226 COVID-19 survivors reported symptoms in the clinical range for at least one psychopathological dimension.
“Three months after discharge from the hospital, 35.8% still self-rated symptoms in the clinical range in at least one psychopathological dimension.”
- Also stated in: § Psychopathology and need for treatment · plain
“Three months after hospital discharge 81/226 patients (35.8%) self-rated symptoms in the clinical range in at least one psychopathological dimension”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
Psychomotor coordination was also influenced by a main effect of SII (χ2 = 7.636, p = 0.0057).
“the latter also influenced by the main effect of SII (χ2 = 7.636, p = 0.0057)”
Quote in the paperSubstantial claim - Findingown data
In less severe patients treated at home, SII was not associated with worse BDI and ZSDS scores.
“but not in less severe patients treated at home, SII associated with worse BDI and ZSDS scores correcting for sex and age”
Quote in the paperSubstantial claim - Findingown data
Baseline SII predicted verbal fluency.
“Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII.”
Quote in the paperSubstantial claim - Findingown data
Only 19% of the 130 assessed patients showed normal performance in all cognitive domains.
“Only 25 patients (19%) showed equivalent scores within the normal range in all domains”
Quote in the paperSubstantial claim - Findingown data
Female sex predicted worse persistence of depressive symptoms at three months after discharge.
“Sex, previous psychiatric history, and the presence of depression at one month affected the depressive symptomatology at three months.”
- Also stated in: § Psychopathology and need for treatment · plain
“Univariate testing showed significantly worse persistence of depressive symptomatology in females (ZSDS: β = 0.21, F = 7.31, p = 0.008; BDI-13: β = 0.27, F = 11.12; p = 0.001)”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
There was an interaction of SII with hospitalization on depression severity.
“the interaction of SII with hospitalization (BDI: χ2 = 7.357, p = 0.0067; ZSDS: χ2 = 3.999, p = 0.0455)”
Quote in the paperSubstantial claim - Findingown data
Duration of hospitalization inversely correlated with three-month scores on ZSDS, BDI-13, IES-R, PCL-5, OCI, and WHIIRS.
“Duration of hospitalization inversely correlated with three months ZSDS (r = −0.23, p = 0.005, q = 0.01), BDI-13 (r = −0.21, p = 0.010, q = 0.015), IES-R (r = −0.20, p = 0.014, q = 0.017), PCL-5 (r = −0.26, p = 0.003, q = 0.01), OCI (r = −0.26, p = 0.004, q = 0.01), and WHIIRS (r = −0.17, p = 0.044, q = 0.044).”
Quote in the paperNot a substantial claim - Findingown data
At three-month follow-up after SARS-CoV-2 infection, isolated persistent depressive symptomatology was present.
“Our main finding is the presence of isolated persistent depressive symptomatology at three months follow-up after SARS-CoV-2 infection”
Quote in the paperSubstantial claim - Findingown data
Psychomotor coordination was impaired in 57% of the sample.
“Regardless of clinical physical severity, 78% of the sample showed poor performances in at least one cognitive domain, with executive functions and psychomotor coordination being impaired in 50% and 57% of the sample.”
- Also stated in: § Discussion · plain
“Executive functions and psychomotor coordination were the most involved domain being impaired in 50% and 57% of the sample”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
There was an interaction of age and sex on depression severity.
“the interaction of age and sex (BDI: χ2 = 8.933, p = 0.0028; ZSDS: χ2 = 5.423, p = 0.0199)”
Quote in the paperNot a substantial claim - Findingown data
Setting of care did not affect self-rated psychopathology at three months.
“Age and setting of the care did not affect self-ratings psychopathology.”
Quote in the paperNot a substantial claim - Findingown data
Psychopathology at one month had a significant effect on neurocognition.
“A GLM multivariate analysis of variance showed significant effects of any kind of psychopathology presented at one (Wilks’ λ = 0.81; F = 3.39; p = 0.004) and three months (Wilks’ λ = 0.82; F = 2.32; p = 0.042) after discharge; but not of sex, previous psychiatric diagnosis, and duration of hospitalization.”
Quote in the paperSubstantial claim - Findingown data
Duration of hospitalization did not affect neurocognition.
“A GLM multivariate analysis of variance showed significant effects of any kind of psychopathology presented at one (Wilks’ λ = 0.81; F = 3.39; p = 0.004) and three months (Wilks’ λ = 0.82; F = 2.32; p = 0.042) after discharge; but not of sex, previous psychiatric diagnosis, and duration of hospitalization.”
Quote in the paperNot a substantial claim - Findingown data
SII at hospital admission and age had a significant interaction on verbal fluency (χ2 = 4.273, p = 0.0387).
“verbal fluency (χ2 = 4.273, p = 0.0387)”
Quote in the paperSubstantial claim - Findingown data
Parameter estimates indicated that SII had a negative effect on neurocognitive performance.
“Analysis of parameter estimates showed a negative effect of SII on performance (Fig. 2 ).”
Quote in the paperSubstantial claim - Findingown data
A drop in SII between admission and three months after discharge significantly influenced the change in depressive symptoms at follow-up as measured by BDI-13 (Wald W2 = 14.304, p = 0.0002; GLM F = 12.37, p = 0.0013).
“The decrease of SII from hospital admission to three months after discharge significantly influenced the change of depressive symptoms at follow-up, as rated both at BDI-13 (Wald W2 = 14.304, p = 0.0002) and at ZSDS (Wald W2 = 6.881, p = 0.0087)”
- Also stated in: § Effect of inflammatory biomarkers · plain
“A GLM repeated measures analysis of variance confirmed a significant interaction of delta SII with time on the pattern of change of both BDI-13 (F = 12.37, d.f. 1,32, p = 0.0013) and ZSDS (F = 5.95, d.f. 1,32, p = 0.0204).”
Quote in the paperSubstantial claim - Also stated in: § Effect of inflammatory biomarkers · plain
- Findingown data
SII at hospital admission and age had a significant interaction on speed of information processing (symbol coding, χ2 = 5.544, p = 0.0185).
“speed of information processing (symbol coding, χ2 = 5.544, p = 0.0185)”
Quote in the paperSubstantial claim - Findingown data
Systemic inflammation during acute infection predicted persistent depressive symptomatology at three months.
“which is predicted by systemic inflammation during acute infection”
Quote in the paperSubstantial claim - Findingown data
Females suffered more in all psychopathological domains at three months.
“Females, patients with a positive previous psychiatric diagnosis, and patients who already presented psychopathological symptoms one month after discharge suffered more in all psychopathological domains (Table 1, Table 2).”
Quote in the paperNot a substantial claim - Findingown data
24.3% of patients showed DSM-5 criteria for a current major psychiatric disorder at three months.
“At the clinical interview 55/226 patients (24.3%) showed DSM-5 criteria for the diagnosis of current major psychiatric disorder (major depressive disorder (n = 20), anxiety disorders (n = 20), insomnia (n = 7), and other diagnoses (n = 8)).”
Quote in the paperSubstantial claim - Findingown data
SII level predicted severity of depressive psychopathology at three months.
“Systemic inflammation (SII level) predicted severity of depressive psychopathology at the three-months follow-up.”
Quote in the paperSubstantial claim - Findingown data
Baseline SII predicted cognitive impairment at three-month follow-up.
“Baseline systemic immune-inflammation index (SII), which reflects the immune response and systemic inflammation based on peripheral lymphocyte, neutrophil, and platelet counts, predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up; and changes of SII predicted changes of depression during follow-up.”
Quote in the paperSubstantial claim - Findingown data
There was a main effect of sex on depression severity, with worse scores in females.
“The significant effects were the main effect of sex (worse scores in females, BDI: χ2 = 30.222, p < 0.0001; ZSDS: χ2 = 20.627, p < 0.0001)”
Quote in the paperNot a substantial claim - Findingown data
Presence of psychopathology at one month predicted worse persistence of depressive symptoms at three months after discharge.
“Sex, previous psychiatric history, and the presence of depression at one month affected the depressive symptomatology at three months.”
- Also stated in: § Psychopathology and need for treatment · plain
“in patients who showed psychopathology one month after discharge (ZSDS: β = 0.41, F = 30.50, p < 0.001; BDI-13: β = 0.26, F = 11.92, p < 0.001)”
Quote in the paperSubstantial claim - Also stated in: § Psychopathology and need for treatment · plain
- Findingown data
There was a triple interaction of SII with age and sex on depression severity.
“and the triple interaction of SII with age and sex (BDI: χ2 = 10.821, p = 0.0010; ZSDS: χ2 = 5.252, p = 0.0219)”
Quote in the paperNot a substantial claim - Findingown data
Patients with psychopathological symptoms at one month suffered more in all psychopathological domains at three months.
“Females, patients with a positive previous psychiatric diagnosis, and patients who already presented psychopathological symptoms one month after discharge suffered more in all psychopathological domains (Table 1, Table 2).”
Quote in the paperSubstantial claim - Findingown data
Patients with psychopathology at one month performed worse on verbal fluency at three months.
“Patients with psychopathology one-month after discharge performed worse on verbal fluency (β = 0.349, p = 0.002), information processing (β = 0.348, p = 0.002), and executive functions (β = 0.353, p = 0.001) at the three months assessment”
Quote in the paperSubstantial claim - Findingown data
34 patients were in need of psychopharmacologic treatment.
“Of them, 34 patients were in need of a psychopharmacologic treatment, 10 patients were already taking drugs, while 24 patients started taking pharmacological treatment.”
Quote in the paperNot a substantial claim - Findingown data
Changes in SII predicted changes in depression during follow-up.
“Baseline systemic immune-inflammation index (SII), which reflects the immune response and systemic inflammation based on peripheral lymphocyte, neutrophil, and platelet counts, predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up; and changes of SII predicted changes of depression during follow-up.”
Quote in the paperSubstantial claim - Findingown data
Patients with a positive previous psychiatric diagnosis suffered more in all psychopathological domains at three months.
“Females, patients with a positive previous psychiatric diagnosis, and patients who already presented psychopathological symptoms one month after discharge suffered more in all psychopathological domains (Table 1, Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Executive functions were impaired in 50% of the sample.
“Regardless of clinical physical severity, 78% of the sample showed poor performances in at least one cognitive domain, with executive functions and psychomotor coordination being impaired in 50% and 57% of the sample.”
- Also stated in: § Discussion · plain
“Executive functions and psychomotor coordination were the most involved domain being impaired in 50% and 57% of the sample”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
Baseline SII predicted psychomotor coordination.
“Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII.”
Quote in the paperSubstantial claim - Findingown data
The pattern of change of systemic inflammation over time predicted persistent depressive symptomatology at three months.
“and by its pattern of change over time.”
Quote in the paperSubstantial claim - Findingown data
Neurocognitive impairments were associated with severity of depressive psychopathology.
“Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII.”
- Also stated in: § Neurocognitive functioning · plain
“In particular, severity of depressive symptoms (ZSDS scores) at one and three months follow-up predicted the performance in information processing (one month: Wald = 7.05, p = 0.007; three months: Wald = 8.37, p = 0.003).”
Quote in the paperSubstantial claim - Also stated in: § Neurocognitive functioning · plain
- Findingown data
Baseline SII predicted processing speed.
“Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII.”
Quote in the paperSubstantial claim - Findingown data
Age had a significant negative main effect on all BACS measures.
“showed a significant negative main effect of age on all measures”
Quote in the paperNot a substantial claim - Findingown data
Patients with psychopathology at one month performed worse on executive functions at three months.
“Patients with psychopathology one-month after discharge performed worse on verbal fluency (β = 0.349, p = 0.002), information processing (β = 0.348, p = 0.002), and executive functions (β = 0.353, p = 0.001) at the three months assessment”
Quote in the paperSubstantial claim - Findingown data
In hospitalized patients, SII was associated with worse BDI and ZSDS scores, correcting for sex and age.
“but not in less severe patients treated at home, SII associated with worse BDI and ZSDS scores correcting for sex and age (BDI: Wald W2 = 19.635, p < 0.0001; ZSDS; Wald W2 = 18.217, p < 0.0001).”
Quote in the paperSubstantial claim - Findingown data
Age did not affect self-rated psychopathology at three months.
“Age and setting of the care did not affect self-ratings psychopathology.”
Quote in the paperNot a substantial claim - Findingown data
Sex, age, and hospitalization had no effect on the change of depressive symptoms in the model of SII decrease and depression change.
“with no effects of sex, age, and hospitalization”
Quote in the paperNot a substantial claim - Findingown data
78% of the sample showed poor performance in at least one cognitive domain, regardless of clinical physical severity.
“Regardless of clinical physical severity, 78% of the sample showed poor performances in at least one cognitive domain, with executive functions and psychomotor coordination being impaired in 50% and 57% of the sample.”
Quote in the paperSubstantial claim - Findingown data
SII at hospital admission and age had a significant interaction on verbal memory (χ2 = 4.908, p = 0.0267).
“a significant interaction of SII and age on verbal memory (χ2 = 4.908, p = 0.0267)”
Quote in the paperSubstantial claim - Findingown data
Patients with psychopathology at one month performed worse on information processing at three months.
“Patients with psychopathology one-month after discharge performed worse on verbal fluency (β = 0.349, p = 0.002), information processing (β = 0.348, p = 0.002), and executive functions (β = 0.353, p = 0.001) at the three months assessment”
Quote in the paperSubstantial claim - Findingown data
Psychopathology at three months had a significant effect on neurocognition.
“A GLM multivariate analysis of variance showed significant effects of any kind of psychopathology presented at one (Wilks’ λ = 0.81; F = 3.39; p = 0.004) and three months (Wilks’ λ = 0.82; F = 2.32; p = 0.042) after discharge; but not of sex, previous psychiatric diagnosis, and duration of hospitalization.”
Quote in the paperSubstantial claim - Findingown data
Severity of depressive symptoms at one month predicted information processing performance.
“In particular, severity of depressive symptoms (ZSDS scores) at one and three months follow-up predicted the performance in information processing (one month: Wald = 7.05, p = 0.007; three months: Wald = 8.37, p = 0.003).”
Quote in the paperSubstantial claim - Findingown data
Psychopathology at three months was associated with worse information processing.
“whereas psychopathology at three months associated with worse information processing (β = 0.355, p = 0.008).”
Quote in the paperSubstantial claim - Findingown data
Hospitalized patients had significantly worse inflammation (SII) than less severe patients treated at home.
“Analysis of parameter estimates showed that in hospitalized patients, who had significantly worse inflammation (SII: 1480.61 ± 1395.47 vs 871.34 ± 711.27; Mann-Whitney U = 1451.00, Z = 2.980, p = 0.0026)”
Quote in the paperNot a substantial claim - Findingown data
Patients with a positive previous psychiatric diagnosis were at higher risk of meeting DSM-5 criteria for a current major psychiatric disorder.
“Patients with positive previous psychiatric diagnosis were at higher risk to show DSM-5 criteria for the diagnosis of current major psychiatric disorder (χ2 = 20.12; p < 0.001 See Supplementary material).”
Quote in the paperSubstantial claim - Findingown data
Baseline SII predicted verbal memory.
“Neurocognitive impairments associated with severity of depressive psychopathology, and processing speed, verbal memory and fluency, and psychomotor coordination were predicted by baseline SII.”
Quote in the paperSubstantial claim - Findingown data
Previous psychiatric diagnosis did not affect neurocognition.
“A GLM multivariate analysis of variance showed significant effects of any kind of psychopathology presented at one (Wilks’ λ = 0.81; F = 3.39; p = 0.004) and three months (Wilks’ λ = 0.82; F = 2.32; p = 0.042) after discharge; but not of sex, previous psychiatric diagnosis, and duration of hospitalization.”
Quote in the paperNot a substantial claim - Findingown data
Baseline SII predicted self-rated depressive symptoms at three-month follow-up.
“Baseline systemic immune-inflammation index (SII), which reflects the immune response and systemic inflammation based on peripheral lymphocyte, neutrophil, and platelet counts, predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up; and changes of SII predicted changes of depression during follow-up.”
- Also stated in: § Effect of inflammatory biomarkers · plain
“Systemic inflammation (SII level) predicted severity of depressive psychopathology at the three-months follow-up.”
Quote in the paperSubstantial claim - Also stated in: § Effect of inflammatory biomarkers · plain
- Findingown data
Oxygen saturation at admission did not affect neurocognition.
“Oxygen saturation level at admission and duration of hospitalization did not affect neurocognition.”
Quote in the paperNot a substantial claim - Findingown data
Sex did not affect neurocognition.
“A GLM multivariate analysis of variance showed significant effects of any kind of psychopathology presented at one (Wilks’ λ = 0.81; F = 3.39; p = 0.004) and three months (Wilks’ λ = 0.82; F = 2.32; p = 0.042) after discharge; but not of sex, previous psychiatric diagnosis, and duration of hospitalization.”
Quote in the paperNot a substantial claim - Findingown data
Severity of depressive symptoms at three months predicted information processing performance.
“In particular, severity of depressive symptoms (ZSDS scores) at one and three months follow-up predicted the performance in information processing (one month: Wald = 7.05, p = 0.007; three months: Wald = 8.37, p = 0.003).”
Quote in the paperSubstantial claim - Findingown data
SII at hospital admission and age had a significant interaction on psychomotor coordination (χ2 = 6.680, p = 0.0097).
“psychomotor coordination (χ2 = 6.680, p = 0.0097)”
Quote in the paperSubstantial claim - Findingown data
A drop in SII between admission and three months after discharge significantly influenced the change in depressive symptoms at follow-up as measured by ZSDS (Wald W2 = 6.881, p = 0.0087; GLM F = 5.95, p = 0.0204).
“The decrease of SII from hospital admission to three months after discharge significantly influenced the change of depressive symptoms at follow-up, as rated both at BDI-13 (Wald W2 = 14.304, p = 0.0002) and at ZSDS (Wald W2 = 6.881, p = 0.0087)”
- Also stated in: § Effect of inflammatory biomarkers · plain
“A GLM repeated measures analysis of variance confirmed a significant interaction of delta SII with time on the pattern of change of both BDI-13 (F = 12.37, d.f. 1,32, p = 0.0013) and ZSDS (F = 5.95, d.f. 1,32, p = 0.0204).”
Quote in the paperSubstantial claim - Also stated in: § Effect of inflammatory biomarkers · plain
- Findingown data
Systemic inflammation at hospital admission predicted neurocognitive performance at three-month follow-up.
“Systemic inflammation also predicted neurocognitive performance.”
- Also stated in: § Effect of inflammatory biomarkers · plain
“Analysis of parameter estimates showed a negative effect of SII on performance (Fig. 2 ).”
Quote in the paperSubstantial claim - Also stated in: § Effect of inflammatory biomarkers · plain
- Findingown data
No association was found between baseline or three-month follow-up levels of other inflammatory markers (CRP, NLR, and MLR) and depression.
“No association was found between other inflammatory markers (CRP, NLR, and MLR) at baseline and three months follow-up and depression.”
Quote in the paperNot a substantial claim - Findingown data
Thirty-four patients needed psychopharmacological treatment.
“Overall, thirty-four patients needed psychopharmacological treatment”
Quote in the paperNot a substantial claim - Findingown data
9% of patients with no previous psychiatric history were started on pharmacological treatment.
“in 9% of patients with no previous psychiatric history were started a pharmacological treatment”
Quote in the paperNot a substantial claim - Findingown data
In the present study, baseline SII predicted severity of depressive psychopathology at three-month follow-up.
“In the present study, we have found that baseline SII predicted severity of depressive psychopathology and neurocognitive performance at”
Quote in the paperSubstantial claim - Findingown data
At three months follow-up, 20 patients (8.9% of the total) met criteria for a depressive episode diagnosis.
“We found at three months follow-up that 20 patients (8.9% of the total) met the criteria for the diagnosis of a depressive episode.”
Quote in the paperSubstantial claim - Findingown data
The observed dysfunctions in attention and information processing were related to systemic inflammation.
“and to systemic inflammation.”
Quote in the paperSubstantial claim - Findingown data
Dysfunctions in attention and information processing were observed in COVID-19 survivors.
“we observed dysfunctions in attention and information processing”
Quote in the paperSubstantial claim - Findingown data
About 30% of the sample showed impairment in information processing, verbal fluency, and working memory.
“information processing, verbal fluency, and working memory were impaired in around 30% of the sample.”
Quote in the paperSubstantial claim - Findingown data
The BDI-13 showed higher consistency with clinical interview findings than the ZSDS.
“the latter showing higher consistency with the clinical interview findings”
Quote in the paperNot a substantial claim - Findingown data
COVID-19 survivors remain clinically depressed three months after hospital discharge.
“COVID-19 survivors remain clinically depressed three months after hospital discharge”
Quote in the paperSubstantial claim - Findingown data
28% of the whole sample scored in the pathological range for depression on the ZSDS index.
“28% of the whole sample scored in the pathological range for depression according to ZSDS index”
Quote in the paperNot a substantial claim - Findingown data
9% of the whole sample scored in the pathological range for depression on the BDI-13.
“9% according to the more conservative BDI-13 (Shafer, 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shafer, 2006 source
Not checked in the free run.
- Findingown data
The observed dysfunctions in attention and information processing were strictly related to depressive symptomatology at one and three months.
“that were strictly related to the presence of depressive symptomatology both at one and three months”
Quote in the paperSubstantial claim - Premisecitation
COVID-19 outbreak is associated with mental health implications during viral infection and at short-term follow-up.
“COVID-19 outbreak is associated with mental health implications during viral infection and at short-term follow-up.”
- Also stated in: § Introduction · plain
“As the pandemic spread, there has been a growing recognition of mental health implications (Amsalem et al., 2020, The Lancet, 2020, Xiang et al., 2020).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Also stated in: § Introduction · plain
- Premisecitation
Viral infections can trigger chronic inflammation and aberrant immune responses, causing long-lasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms over variable periods after infection.
“Current knowledge suggests that viral infections can trigger chronic inflammation and aberrant immune responses, causing long-lasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms, over highly variable periods after infection (from weeks to years following acute infection) (Bechter, 2013, Kepinska et al., 2020, Lam et al., 2009, Rogers et al., 2020).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Severity of psychiatric symptoms after virus clearance is proportional to the severity of systemic inflammation during the acute infection.
“with severity of psychiatric symptoms after virus clearance being proportional to the severity of systemic inflammation during the acute infection and significantly contributing to the quality of life of survivors (De Lorenzo et al., 2020, Ma et al., 2020, Mazza et al., 2020, Varatharaj et al., 2020).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
After recovery from SARS or MERS, more than 15% of patients showed deficits in memory, attention, concentration, or mental processing speed at follow-up periods of 6 weeks to 39 months.
“In SARS and MERS, after recovery from the infection, impairment of memory, attention, concentration, or mental processing speed were reported in more than 15% of patients at a follow-up period ranging between 6 weeks and 39 months (Hopkins et al., 1999, Sheng et al., 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationnone given
Depression affects neurocognitive performances.
“Depression also affects neurocognitive performances”
Quote in the paperSubstantial claim - Premisecitation
COVID-19 causes a strong immune response with elevated levels of certain cytokines including IL-1β, IL-4, IL-6, IL-10, TNF-α, CXCL10, and CCL2.
“COVID-19 induces a robust immune response characterized by a hyperinflammatory state with high levels of IL-1β, IL-4, IL-6, IL-10, TNF-α CXCL10, and CCL2 (Mehta et al., 2020, Ye et al., 2020).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Mehta et al., 2020 source
Not checked in the free run.
- cites Ye et al., 2020
Not checked in the free run.
- Interpretationreasoning
Depression and neurocognitive impairment possibly share the same inflammatory triggers.
“possibly sharing the same inflammatory triggers”
Quote in the paperSubstantial claim - Study design and conductown data
The subgroup of patients with inflammatory state assessment at three months is too small to generalize the findings over time.
“The subgroup of patients with assessment of the inflammatory state at three months is too small to generalize our findings over time”
Quote in the paperSubstantial claim
- May combine two claims. 27
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 33
May combine two claims.
Findingown dataAt low levels of systemic inflammation, depression ratings were widely dispersed, and more severe depressive symptoms occurred at higher inflammation levels.
“Inspection of data (Fig. 1 ) shows highly dispersed depression ratings at low levels of inflammation, with more severe symptoms at higher levels of inflammation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data9% of patients with no previous psychiatric history and 32% with a positive previous psychiatric history were prescribed psychotropic drugs.
“Overall, 9% of patients with no previous psychiatric history and 32% of patients with positive previous psychiatric history were prescribed psychotropic drugs (selective serotonin reuptake inhibitors alone, or combined with sleep-inducing benzodiazepines).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPatients with a marked decrease in SII showed a decrease in depression severity, whereas patients with minor changes in SII had persistent or worsening depression.
“patients who showed a marked decrease of SII also showed a decrease of depression severity, while patients who showed minor changes of SII showed persistent or worsening depression.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataPrevious psychiatric history predicted worse persistence of depressive symptoms at three months after discharge.
“Sex, previous psychiatric history, and the presence of depression at one month affected the depressive symptomatology at three months.”
- Also stated in: § Psychopathology and need for treatment · plain
“in patients with previous lifetime psychiatric history (ZSDS: β = 0.15, F = 4.66, p = 0.32; BDI-13: β = 0.23, F = 10.65, p = 0.001)”
Quote in the paperSubstantial claim- Also stated in: § Psychopathology and need for treatment · plain
May combine two claims.
Findingown dataBest performing models according to AIC included SII and significantly explained variation in depression severity.
“A GLZM analysis of the effects of SII at hospital admission on severity of depression at three months, also considering sex, hospitalization, and age as factors, showed that best performing models according to AIC always included SII and significantly explained the variation of depression severity (χ2 = 56.536, p < 0.0001 for BDI; χ2 = 42.417, p < 0.0001 for ZSDS index scores).”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
FindingreasoningPTSD, insomnia, and anxiety decrease over time.
“other symptoms probably more related to acute psychological stressors such as PTSD, insomnia, and anxiety decrease over time”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningAttention and information processing, verbal memory, and psychomotor coordination were among the affected cognitive domains.
“attention and information processing, verbal memory, and psychomotor coordination were among the affected domains”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationFemales, patients with a positive psychiatric history, patients with shorter hospitalization, and patients with psychopathology at one-month follow-up had higher depressive symptomatology.
“we observed that females, patients with positive psychiatric history, patients with shorter hospitalization, and patients who presented psychopathology at one-month follow-up showed higher depressive symptomatology (Mazza et al., 2020)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mazza et al., 2020 source
Not checked in the free run.
May combine two claims.
Findingown dataAt three months, a high rate of cognitive deficits was observed in COVID-19 survivors regardless of medical severity, with only 22% performing well in all investigated domains.
“Consistently with previous literature, we observed a high rate of cognitive deficits in COVID-19 survivors at three months, irrespective of medical severity of the illness, with only 22% of the sample showing a good performance in all the investigated domains.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenLevels of significance were corrected for multiple comparisons using the FDR method.
“When appropriate, levels of significance were corrected for multiple comparisons with the method of the adaptive linear step-up procedures that control the FDR and q-values (FDR-adjusted p-value) were considered.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationValidated self-report questionnaires were used to assess psychopathology.
“Validated self-report questionnaires were used to assess psychopathology: Impact of Event Scale - Revised (IES-R) (Creamer et al., 2003), PTSD Checklist for DSM-5 (PCL-5) (Armour et al., 2016), Zung Self-Rating Depression Scale (ZSDS) (Zung, 1965), 13-item Beck’s Depression Inventory (BDI-13) (Beck and Steer, 1984), State-Trait Anxiety Inventory form Y (STAI-Y) (Vigneau and Cormier, 2008), Women’s”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Study design and conductown dataThe three-month follow-up cohort did not differ from the drop-out group or the initial cohort in sociodemographic characteristics, clinical severity, or one-month psychopathology after FDR correction.
“The three-month follow-up cohort did not differ from the drop-out group and from the initial cohort in terms of sociodemographic characteristics, clinical severity, and one-month psychopathology after False Discovery Rate (FDR) correction (See Supplementary material).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationCognitive assessment used the Brief Assessment of Cognition in Schizophrenia (BACS) with normative Italian scores, and patients older than 70 years were excluded.
“Considering that domain scores were adjusted according to normative Italian scores for the BACS subtests in patients aged 18–70 years, we did not perform cognitive assessment in patients older than 70 years (Anselmetti et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Anselmetti et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationCOVID-19 is associated with delirium, fatigue, confusion, depression, anxiety, PTSD, obsessive-compulsive symptoms, and insomnia in acute infection or short-term follow-up.
“Emerging data show that COVID-19 outbreak is associated with delirium, fatigue, confusion, depression, anxiety, post-traumatic stress disorder (PTSD), obsessive–compulsive symptoms, and insomnia in the context of acute viral infection or at short-term follow-up after clinical recovery”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe host immune response to SARS-CoV-2, persistent psychological stress, and possible direct viral infection of the central nervous system are possible mechanisms for neuropsychiatric sequelae.
“The host immune response to SARS-CoV-2 infection, the persistent psychological stress before and during infection (Korman et al., 2020, Vai et al., 2020), and a possible direct viral infections of the central nervous system represent possible mechanisms to induce neuropsychiatric sequelae (Troyer et al., 2020).”
Quote in the paperSubstantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
PremisecitationT helper (Th)-1 and Th-2 cytokines are elevated in the serum of COVID-19 patients in a cytokine storm typically associated with the illness.
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coperchini et al., 2020 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPeripheral cytokines involved in the host anti-viral response may elicit psychiatric symptoms by precipitating inflammation in the periphery and central nervous system.
“Peripheral cytokines involved in the host anti-viral response may elicit psychiatric symptoms by precipitating inflammation in the periphery and in central nervous system (CNS) (Dantzer, 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dantzer, 2018 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSignificant stressors such as fear of severe and unknown disease, loneliness, stigma, and denial contribute to widespread emotional distress and increased risk for psychiatric illness in COVID-19 patients.
“Moreover, significant stressors such as fear of severe and unknown disease, loneliness, stigma, and the denial contribute to widespread emotional distress and increased risk for psychiatric illness in COVID-19 patients (Pfefferbaum and North, 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pfefferbaum and North, 2020 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningPTSD, anxiety, and insomnia decreased in parallel over time, suggesting specific long-lasting depressive sequelae in COVID-19 survivors.
“A parallel decrease of PTSD, anxiety and insomnia over time suggests specific long lasting depressive sequelae in COVID-19 survivors.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationHigher immune/inflammatory setpoints with higher circulating biomarkers of inflammation are observed in mood disorders and are investigated as pathogenetic mechanisms for depressive psychopathology.
“Higher immune/inflammatory setpoints with higher circulating biomarkers of inflammation are observed in mood disorders in the absence of known triggering factors, and are currently investigated as underpinning pathogenetic mechanisms for depressive psychopathology (Gibney and Drexhage, 2013, Grosse et al., 2015, Poletti et al., 2020b).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Gibney and Drexhage, 2013
Not checked in the free run.
- cites Grosse et al., 2015 source
Not checked in the free run.
- cites Poletti et al., 2020b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe quality of the statistical model was checked using the Akaike information criterion (AIC).
“The quality of the statistical model was checked using the entropy maximization principle of the Akaike information criterion (AIC) (Akaike, 1974).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Akaike, 1974 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningPTSD, insomnia, and anxiety are probably more related to acute psychological stressors.
“other symptoms probably more related to acute psychological stressors such as PTSD, insomnia, and anxiety”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConvalescent COVID-19 patients with elevated NLR have been reported to have more depression.
“This finding is consistent with the reported higher depression in convalescent COVID-19 patients with higher NLR (Yuan et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yuan et al., 2020 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn COVID-19, a dysexecutive syndrome was described in one third of survivors.
“In COVID-19, a dysexecutive syndrome in a third of survivors was described (Helms et al., 2020)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Helms et al., 2020 source
Not checked in the free run.
May combine two claims.
PremisecitationIn hospitalized male survivors of severe life-threatening COVID-19, cytokine-blocking agents anakinra and tocilizumab had a protective effect against depression, possibly by reducing SII.
“We also observed a protective effect against depression of cytokine-blocking agents (anakinra, a recombinant version of the human IL-1β receptor antagonist, and tocilizumab, a monoclonal antibody targeting the IL-6 receptor), possibly associated with their effect in dampening SII, in hospitalized male patients surviving severe, life-threatening COVID-19 (Benedetti et al., 2020b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Benedetti et al., 2020b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe study used an unstructured interview format instead of a structured clinical interview because of limited health care resources and patient compliance.
“The limited health care resources and patient’s compliance related to the clinical setting forced us to choose an unstructured interview format instead of a structured clinical interview.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationIn patients with a depressive episode in major depressive disorder or bipolar disorder, IL-8, IL-10, TNF-α, and IFN-γ are associated with white matter microstructure.
“and of IL-8, IL-10, TNF-α, IFN-γ with white matter (WM) microstructure, with levels of inflammatory cytokines being inversely related with measures of WM integrity (Benedetti et al., 2016)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Benedetti et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationSII, by combining three complementary cell types that mediate different immune or inflammatory pathways, is less affected by confounding conditions and more predictive of chronic systemic inflammatory status than neutrophils, platelets, or lymphocytes separately.
“Considering together three complementary cells mediating different immune or inflammatory pathways, SII is less affected by confounding conditions, and more predictive in evaluating chronic systemic inflammatory status than neutrophils, platelets or lymphocytes separately (Gibson et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gibson et al., 2007 source
Not checked in the free run.
- Rests on an assumption: Platelets act as a nonspecific early inflammatory marker, mediating endothelial permeability and drawing neutrophils and macrophages and their effector functions.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn COVID-19, cognitive dysfunction in sustained attention has been described, possibly linked to underlying inflammatory processes measured with CRP.
“as well as cognitive dysfunction in sustained attention domain possibly linked to the underlying inflammatory processes measured with CRP (Zhou et al., 2020a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhou et al., 2020a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany studies have suggested that inflammation activation is linked to cognitive dysfunction, with a primary role for IL-1β, IL-6, IL-18, and TNF-α.
“Many studies have implied that inflammation activation is inextricably linked to cognitive dysfunction suggesting a primary role of IL-1β, IL-6, IL-18, and TNF-α (Beydoun et al., 2019, Gorelick, 2010, McAfoose and Baune, 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn previous work, higher SII-quantified inflammation was associated with greater depression in COVID-19 survivors.
“In this context, we have previously found that higher inflammation, quantified by SII, is associated with higher depression in COVID-19 survivors (Mazza et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mazza et al., 2020 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationLifetime speed of information processing is closely associated with white matter microstructure in humans and animal models.
“the lifetime speed of information processing closely associates with WM microstructure in humans and in animal models (Bartzokis et al., 2012, Kochunov et al., 2007, Lu et al., 2013)”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationElevated NLR has been described in mild cognitive impairment, and platelet/lymphocyte ratio and SII have been associated with dementia risk in the general population.
“Recently, elevated NLR was described in mild cognitive impairment, while platelet/lymphocyte ratio and SII associated with risk of dementia in the general population (An et al., 2019, van der Willik et al., 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites An et al., 2019
Not checked in the free run.
- cites van der Willik et al., 2019 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe white matter phenotype is associated with neurocognitive dysfunctions.
“We also associated this WM phenotype with neurocognitive dysfunctions (Poletti et al., 2015)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Poletti et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn patients with a depressive episode in major depressive disorder or bipolar disorder, peripheral levels of IL-8, TNF-α, CCL2, and CCL4 are associated with cortical thickness.
“In patients with a depressive episode in course of Major Depressive Disorder (MDD) or Bipolar Disorder (BD), we have previously reported an association of peripheral IL-8, TNF-α, CCL2, CCL4 with cortical thickness (Poletti et al., 2019)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Poletti et al., 2019 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the same patient group, IL-1β, IL-9, and CCL5 are associated with brain glutamate, N-acetylaspartate, and Myo-Inositol levels.
“of IL‐1β, IL-9, CCL5 with brain glutamate, N-acetylaspartate, and Myo-Inositol levels (Poletti et al., 2020a)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Poletti et al., 2020a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeutrophils are critical for initiating and regulating innate immune defense through phagocytosis, apoptosis, chemotaxis, oxidative stress, and secretion of inflammatory mediators.
“Neutrophils are critical for starting and regulating the innate immune defense through phagocytosis, apoptotic action, chemotactic role, oxidative stress, and secretion of inflammatory mediators (Nathan, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nathan, 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningChanges in structural and functional brain connectivity might mediate how COVID-19 harms neurocognition.
“we can surmise that subtle effects on structural and functional brain connectivity could mediate the detrimental effects of COVID-19 on neurocognition”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the same patient group, inflammatory cytokine levels are inversely related to measures of white matter integrity.
“with levels of inflammatory cytokines being inversely related with measures of WM integrity (Benedetti et al., 2016)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Benedetti et al., 2016 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe observed cognitive effects were influenced by both psychopathology and systemic inflammation, supporting a connection among depression, inflammation, and cognition.
“These effects were influenced both, by the presence of psychopathology, and by systemic inflammation, thus confirming the connection between depression, inflammation, and cognition.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDepressed patients have higher cytokine levels than healthy controls, with consistent literature findings for IL-1β, IL-6, IL-10, CCL2, TNF-α, and TGF-β.
“Depressed patients are characterized by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL-6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019, Eyre et al., 2016, Howren et al., 2009, Kohler et al., 2017, Poletti et al., 2020b).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataNeurocognition was assessed only in a subsample, not in all patients.
“we were not able to assess the neurocognition in all patients but only in a subsample”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationSII, which combines neutrophils, platelets, and lymphocytes, is an objective marker of the balance between systemic inflammation and immune response.
“SII, considering together neutrophil, platelet, and lymphocyte, is an objective marker of the balance between host systemic inflammation and immune response (Huang et al., 2019).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Huang et al., 2019 source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningRecruitment was in a single center, raising the possibility of population stratification.
“Recruitment was in a single center, thus raising the possibility of population stratification”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationSeveral studies have shown that inflammatory ratios can be used as biomarkers in depression.
“Several studies have proven that these inflammatory ratios can be used as inflammatory biomarkers in depression (Mazza et al., 2018, Wang et al., 2021, Zhou et al., 2020b).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLymphocytes mainly serve adaptive immunity and have a regulatory or protective role.
“Finally, lymphocytes are primarily involved in adaptive immunity, with a regulatory or protective function (Alberts, 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Alberts, 2008
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationInflammation is associated with depression through mechanisms including blood-brain barrier disruption, microglial activation, altered neurotransmission, IDO activation, and oxidative stress.
“Inflammation is known to be associated to depression inducing brain-blood-barrier disruption, microglia activation, neurotransmission alteration, indoleamine 2,3-dioxygenase 1 (IDO) activation, and oxidative stress (Benedetti et al., 2020a, Miller and Raison, 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Benedetti et al., 2020a
Not checked in the free run.
- cites Miller and Raison, 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSerotonin, dopamine, glutamate, cytokines, and P-selectin mediate platelet activation, and all are important in psychiatric disorders.
“Platelet activation is mediated by serotonin, dopamine, glutamate, cytokines and P-selectin, all of them plays an important role in psychiatric disorders (Dietrich-Muszalska and Wachowicz, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dietrich-Muszalska and Wachowicz, 2017 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe effect on neurocognitive dysfunctions is proportional to illness duration.
“an effect proportional to illness duration (Melloni et al., 2019)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Melloni et al., 2019 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThese effects will have substantial and demanding public health implications for psychiatric services.
“the public health implications of such effects will be significant and demanding for the psychiatric services”
Quote in the paperNot a substantial claim- Rests on an assumption: COVID-19 infection has a global burden.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNLR, MLR, and SII are low-cost, reproducible markers of systemic inflammation suitable for routine clinical analysis and easily derived from blood cell assays under simple laboratory conditions.
“NLR, MLR and SII are low-cost, suitable for clinical routine analysis, and reproducible markers of the systemic inflammatory response, which can be easily derived from blood cell essay and determined under simple laboratory conditions (Balta et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Balta et al., 2013 source
Not checked in the free run.
The paper relies on this without support.
The delayed or long-term incidence of neuropsychiatric complications in COVID-19 survivors is unknown.
“Beyond acute or sub-acute sequelae, the delayed or long-term incidence of neuropsychiatric complications in COVID-19 survivors are still unknown.”
The paper relies on this without support.
This was the first prospective study to investigate psychiatric and neurocognitive sequelae at medium-term follow-up in COVID-19 survivors.
“This is the first study to prospectively investigate the psychiatric and neurocognitive sequelae at a medium-term follow-up in COVID-19 survivors.”
The paper relies on this without support.
Platelets act as a nonspecific early inflammatory marker, mediating endothelial permeability and drawing neutrophils and macrophages and their effector functions.
“Platelets are an aspecific first line inflammatory marker that mediate endothelial permeability and recruitment of neutrophils and macrophages and their effector functions.”
The paper relies on this without support.
Depression is associated with a markedly increased risk of all-cause and cause-specific mortality.
“depression associates with a markedly increased risk of all-cause and cause-specific mortality”
The paper relies on this without support.
COVID-19 infection has a global burden.
“given the global burden of COVID-19 infection”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This sensitivity analysis corroborates Mazza et al. (2021), who found that PCL-5-reported PTSD declined with longer follow-up in COVID-19 patients.
“This confirms results from Mazza et al. (2021) where PTSD reported using PCL-5 decreased with longer follow-up in COVID-19 patients.”
From Long-term effects of COVID-19 on mental health: a systematic review (2022) · cites this paper as Mazza et al., 2021
The neurological sequelae of SARS-CoV-2 infection are proving to be both common and debilitating.
“It is thus not surprising that the neurological sequelae of SARS-CoV-2 infection are proving to be both common and debilitating (Nasserie et al., 2021; Mazza et al., 2021; Qureshi et al., 2022; Becker et al., 2021; Tabacof et al., 2022).”
From Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation (2022) · cites this paper as Mazza et al., 2021
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = 2.98reported p = .0026 · recomputed p = .003
“Z = 2.980, p = .0026”
The paper states an exact rank test
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
BDI-13 clinical cutoff changes between methods and results
MinorThe methods define the BDI-13 cutoff as at least 9, but Table 1 counts patients using a cutoff of at least 8.
“BDI-13 ≥ 8 Yes (%)”
“BDI-13 ≥ 9”
Cognitive-performance categories omit 21 assessed patients
MinorThe listed mutually exclusive categories total 109 patients, although the paper says cognitive functions were assessed in 130 patients. The account does not identify a category for the remaining 21.
Reported 130 · recomputed 109
“Only 25 patients (19%) showed equivalent scores within the normal range in all domains, whereas 21 (16%) were poor performers in at least one function, 22 (17%) in two, 18 (14%) in three, 14 (11%) in four, 7 (5%) in five, and 2 (1.5%) showed no good performance at all.”
Share with normal cognition changes from 19% to 22%
MinorThe results say 19% performed normally in every domain, while the discussion describes the same outcome as 22% of the sample.
“Only 25 patients (19%) showed equivalent scores within the normal range in all domains”
“only 22% of the sample showing a good performance in all the investigated domains.”
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879 · cited 2× · see citing works
“A GLZM analysis of the effects of SII at hospital admission on severity of depression at three months, also considering sex, hospitalization, and age as factors, showed that best performing models according to AIC always included SII and significantly explained the variation of depression severity (χ2 = 56.536, p < 0.…”
Influential(2005) · Springer eBooks · doi:10.1007/0-387-27255-0_9 · Cited by 20,333 · see citing works
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836 · see citing works
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 1× · see citing works
“…Scale - Revised (IES-R) (Creamer et al., 2003), PTSD Checklist for DSM-5 (PCL-5) (Armour et al., 2016), Zung SelfRating Depression Scale (ZSDS) (Zung, 1965), 13-item Beck’s Depression Inventory (BDI-13) (Beck and Steer, 1984), State-Trait Anxiety Inventory form Y (STAI-Y) (Vigneau and Cormier,…”
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · cited 4× · see citing works
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically assoc…”
InfluentialAn Introduction to Categorical Data Analysis
Agresti, A. (2006) · Wiley series in probability and statistics · doi:10.1002/0470114754 · Cited by 6,697 · see citing works
WHO Coronavirus Disease (COVID-19) Dashboard
(2020) · Bangladesh Physiotherapy Journal · doi:10.46945/bpj.10.1.03.01 · Cited by 5,545 · see citing works
Alberts, B., Johnson, A. D., Lewis, J. H., RAFF, M. C., Roberts, K. J., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,591 · see citing works
Mental health and the COVID-19 pandemic
Pfefferbaum, B., & North, C. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2008017 · Cited by 4,378 · cited 1× · see citing works
“Moreover, significant stressors such as fear of severe and unknown disease, loneliness, stigma, and the denial contribute to widespread emotional distress and increased risk for psychiatric illness in COVID-19 patients (Pfefferbaum and North, 2020).”
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 2× · see citing works
“…al. Brain Behavior and Immunity 94 (2021) 138–147 M.G. Mazza et al. Brain Behavior and Immunity 94 (2021) 138–147 disruption, microglia activation, neurotransmission alteration, indoleamine 2,3-dioxygenase 1 (IDO) activation, and oxidative stress (Benedetti et al., 2020a; Miller and Raison, 2016).”
Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed
Xiang, Y.-T., Yang, Y., Li, W., Zhang, L., Zhang, Q., Cheung, T., & Ng, C. H. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30046-8 · Cited by 3,598 · see citing works
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 1× · see citing works
“Neutrophils are critical for starting and regulating the innate immune defense through phagocytosis, apoptotic action, chemotactic role, oxidative stress, and secretion of inflammatory mediators (Nathan, 2006).”
The Obsessive-Compulsive Inventory: Development and validation of a short version.
Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002) · Psychological Assessment · doi:10.1037/1040-3590.14.4.485 · Cited by 2,959 · cited 7× · see citing works
“To investigate changes of psychopathology over time, repeated measures ANOVAs (according to sex and psychiatric history) were performed, considering ZSDS, BDI-13, IES-R, PCL-5, STAI-Y, OCI, and WHIIRS scores at one- and three-months follow-up.”
InfluentialAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · cited 1× · see citing works
“Depressed patients are characterized by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019; Eyre et al., 2016; Howren et al., 2009; Kohler et al., 2017; Poletti…”
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761 · see citing works
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674 · cited 1× · see citing works
“In COVID-19, a dysexecutive syndrome in a third of survivors was described (Helms et al., 2020), as well as cognitive dysfunction in sustained attention domain possibly linked to the underlying inflammatory processes measured with CRP (Zhou et al.”
An Introduction to Generalized Linear Models.
Chang, P. C., & Dobson, A. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290548 · Cited by 2,543 · see citing works
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407 · cited 1× · see citing works
“Current knowledge suggests that viral infections can trigger chronic inflammation and aberrant immune responses, causing longlasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms, over highly variable periods after infection (from weeks to years following acute infection) (Bechter…”
InfluentialAn Introduction to Categorical Data Analysis
Musiol, G. (1997) · Computational Statistics & Data Analysis · doi:10.1016/s0167-9473(97)84760-3 · Cited by 1,984 · see citing works
Psychometric properties of the Impact of Event Scale—Revised
Creamer, M., Bell, R., & Failla, S. (2003) · Behaviour Research and Therapy · doi:10.1016/j.brat.2003.07.010 · Cited by 1,947 · cited 8× · see citing works
“To investigate changes of psychopathology over time, repeated measures ANOVAs (according to sex and psychiatric history) were performed, considering ZSDS, BDI-13, IES-R, PCL-5, STAI-Y, OCI, and WHIIRS scores at one- and three-months follow-up.”
InfluentialAnxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804 · cited 5× · see citing works
“Considering the high prevalence of emergent psychiatric conditions that we have observed at one-month follow-up (Mazza et al., 2020) and surmising persistent delayed post-viral psychiatric and cognitive sequelae, here we aimed at studying psychopathological and neurocognitive impact of COVID-19 in survivors three-mont…”
InfluentialSelf-citationKeefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573 · cited 3× · see citing works
“Considering that domain scores were adjusted according to normative Italian scores for the BACS subtests in patients aged 18–70 years, we did not perform cognitive assessment in patients older than 70 years (Anselmetti et al., 2008).”
InfluentialPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 1× · see citing works
“Depressed patients are characterized by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019; Eyre et al., 2016; Howren et al., 2009; Kohler et al., 2017; Poletti…”
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288 · cited 1× · see citing works
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically assoc…”
Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30287-x · Cited by 1,246 · see citing works
Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa
Dantzer, R. (2018) · Physiological Reviews · doi:10.1152/physrev.00039.2016 · Cited by 1,073 · cited 1× · see citing works
“Peripheral cytokines involved in the host anti-viral response may elicit psychiatric symptoms by precipitating inflammation in the periphery and in central nervous system (CNS) (Dantzer, 2018).”
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964 · cited 1× · see citing works
“, 2020), and a possible direct viral infections of the central nervous system represent possible mechanisms to induce neuropsychiatric sequelae (Troyer et al., 2020).”
Shafer, A. B. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20213 · Cited by 837 · see citing works
Evidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760 · cited 3× · see citing works
“In patients with a depressive episode in course of Major Depressive Disorder (MDD) or Bipolar Disorder (BD), we have previously reported an association of peripheral IL-8, TNF-α, CCL2, CCL4 with cortical thickness (Poletti et al., 2019); of IL-1β, IL-9, CCL5 with brain glutamate, N-acetylaspartate, and Myo-Inositol le…”
Lam, M. H.-B. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.384 · Cited by 723 · cited 1× · see citing works
“Current knowledge suggests that viral infections can trigger chronic inflammation and aberrant immune responses, causing longlasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms, over highly variable periods after infection (from weeks to years following acute infection) (Bechter…”
InfluentialHOPKINS, R. O., WEAVER, L. K., POPE, D., ORME, J. F., BIGLER, E. D., & LARSON-LOHR, V. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9708059 · Cited by 668 · cited 1× · see citing works
“In SARS and MERS, after recovery from the infection, impairment of memory, attention, concentration, or mental processing speed were reported in more than 15% of patients at a followup period ranging between 6 weeks and 39 months (Hopkins et al., 1999; Sheng et al., 2005).”
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615 · cited 1× · see citing works
“Depressed patients are characterized by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019; Eyre et al., 2016; Howren et al., 2009; Kohler et al., 2017; Poletti…”
Hill, T., & Lewicki, P. (2006) · Medical Entomology and Zoology · Cited by 587 · see citing works
The landscape of cognitive function in recovered COVID-19 patients
Zhou, H., Lu, S., Chen, J., Wei, N., Wang, D., Lyu, H., Shi, C., & Hu, S. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.06.022 · Cited by 440 · see citing works
Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer
Huang, H., Liu, Q., Zhu, L., Zhang, Y., Lu, X., Wu, Y., & Liu, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39150-0 · Cited by 408 · cited 1× · see citing works
“SII, considering together neutrophil, platelet, and lymphocyte, is an objective marker of the balance between host systemic inflammation and immune response (Huang et al., 2019).”
Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting
Gibson, P. H., Croal, B. L., Cuthbertson, B. H., Small, G. R., Ifezulike, A. I., Gibson, G., Jeffrey, R. R., Buchan, K. G., El-Shafei, H., & Hillis, G. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.043 · Cited by 382 · see citing works
Gorelick, P. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05726.x · Cited by 361 · cited 3× · see citing works
“In patients with a depressive episode in course of Major Depressive Disorder (MDD) or Bipolar Disorder (BD), we have previously reported an association of peripheral IL-8, TNF-α, CCL2, CCL4 with cortical thickness (Poletti et al., 2019); of IL-1β, IL-9, CCL5 with brain glutamate, N-acetylaspartate, and Myo-Inositol le…”
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326 · cited 1× · see citing works
“Several studies have proven that these inflammatory ratios can be used as inflammatory biomarkers in depression (Mazza et al., 2018; Wang et al., 2021; Zhou et al., 2020b).”
Self-citationReliability and validity of Women's Health Initiative Insomnia Rating Scale.
Levine, D. W., Lewis, M. A., Bowen, D. J., Kripke, D. F., Kaplan, R. M., Naughton, M. J., & Shumaker, S. A. (2003) · Psychological Assessment · doi:10.1037/1040-3590.15.2.137 · Cited by 283 · see citing works
Neuroinflammation in Bipolar Depression
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00071 · Cited by 281 · see citing works
Self-citationKochunov, P., Thompson, P. M., Lancaster, J. L., Bartzokis, G., Smith, S., Coyle, T., Royall, D. R., Laird, A., & Fox, P. T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.021 · Cited by 250 · see citing works
Association between Systemic Immune-Inflammation Index and Diabetic Depression
Wang, J., Zhou, D., Dai, Z., & Li, X. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s285000 · Cited by 238 · cited 1× · see citing works
“Several studies have proven that these inflammatory ratios can be used as inflammatory biomarkers in depression (Mazza et al., 2018; Wang et al., 2021; Zhou et al., 2020b).”
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Gibney, S. M., & Drexhage, H. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9462-8 · Cited by 237 · cited 1× · see citing works
“Higher immune/inflammatory setpoints with higher circulating biomarkers of inflammation are observed in mood disorders in the absence of known triggering factors, and are currently investigated as underpinning pathogenetic mechanisms for depressive psychopathology (Gibney and Drexhage, 2013; Grosse et al., 2015; Polet…”
Ma, Y.-F., Li, W., Deng, H.-B., Wang, L., Wang, Y., Wang, P., Bo, H., Cao, J., Wang, Y., Zhu, L., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.033 · Cited by 228 · cited 1× · see citing works
“Emerging data show that COVID-19 outbreak is associated with delirium, fatigue, confusion, depression, anxiety, posttraumatic stress disorder (PTSD), obsessive–compulsive symptoms, and insomnia in the context of acute viral infection or at short-term follow-up after clinical recovery, with severity of psychiatric symp…”
Kępińska, A. P., Iyegbe, C. O., Vernon, A. C., Yolken, R., Murray, R. M., & Pollak, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00072 · Cited by 193 · cited 1× · see citing works
“Current knowledge suggests that viral infections can trigger chronic inflammation and aberrant immune responses, causing longlasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms, over highly variable periods after infection (from weeks to years following acute infection) (Bechter…”
InfluentialA meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188 · cited 1× · see citing works
“Depressed patients are characterized by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019; Eyre et al., 2016; Howren et al., 2009; Kohler et al., 2017; Poletti…”
Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study
De Lorenzo, R., Conte, C., Lanzani, C., Benedetti, F., Roveri, L., Mazza, M. G., Brioni, E., Giacalone, G., Canti, V., Sofia, V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239570 · Cited by 179 · see citing works
Korman, M., Tkachev, V., Reis, C., Komada, Y., Kitamura, S., Gubin, D., Kumar, V., & Roenneberg, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-79299-7 · Cited by 161 · cited 2× · see citing works
“The host immune response to SARS-CoV-2 infection, the persistent psychological stress before and during infection (Korman et al., 2020; Vai et al., 2020), and a possible direct viral infections of the central nervous system represent possible mechanisms to induce neuropsychiatric sequelae (Troyer et al.”
Bartzokis, G., Lu, P. H., Heydari, P., Couvrette, A., Lee, G. J., Kalashyan, G., Freeman, F., Grinstead, J. W., Villablanca, P., Finn, J. P., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.010 · Cited by 152 · cited 1× · see citing works
“Consistent with the present findings, attention and information processing, verbal memory, and psychomotor coordination were among the affected domains, and given that the lifetime speed of information processing closely associates with WM microstructure in humans and in animal models (Bartzokis et al., 2012; Kochunov…”
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Mazza, E., Ambrée, O., de Wit, H., Wijkhuijs, A. J. M., Locatelli, C., Bollettini, I., Colombo, C., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.047 · Cited by 151 · cited 1× · see citing works
“, 2020a); and of IL-8, IL-10, TNF-α, IFN-γ with white matter (WM) microstructure, with levels of inflammatory cytokines being inversely related with measures of WM integrity (Benedetti et al., 2016).”
Self-citationAmsalem, D., Dixon, L., & Neria, Y. (2020) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2020.1730 · Cited by 147 · see citing works
The brief assessment of cognition in schizophrenia. Normative data for the Italian population
Anselmetti, S., Poletti, S., Ermoli, E., Bechi, M., Cappa, S., Venneri, A., Smeraldi, E., & Cavallaro, R. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0866-9 · Cited by 129 · cited 1× · see citing works
“Considering that domain scores were adjusted according to normative Italian scores for the BACS subtests in patients aged 18–70 years, we did not perform cognitive assessment in patients older than 70 years (Anselmetti et al., 2008).”
Self-citationPoletti, S., Vai, B., Mazza, M. G., Zanardi, R., Lorenzi, C., Calesella, F., Cazzetta, S., Branchi, I., Colombo, C., Furlan, R., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110136 · Cited by 127 · see citing works
Self-citationNeutrophil to lymphocyte ratio may be predict of mortality in all conditions
Balta, S., Demirkol, S., Unlu, M., Arslan, Z., & Celik, T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.598 · Cited by 124 · cited 1× · see citing works
“NLR, MLR and SII are low-cost, suitable for clinical routine analysis, and reproducible markers of the systemic inflammatory response, which can be easily derived from blood cell essay and determined under simple laboratory conditions (Balta et al., 2013).”
The Factor Structure of the State-Trait Anxiety Inventory: An Alternative View
Vigneau, F., & Cormier, S. (2008) · Journal of Personality Assessment · doi:10.1080/00223890701885027 · Cited by 122 · cited 5× · see citing works
“To investigate changes of psychopathology over time, repeated measures ANOVAs (according to sex and psychiatric history) were performed, considering ZSDS, BDI-13, IES-R, PCL-5, STAI-Y, OCI, and WHIIRS scores at one- and three-months follow-up.”
InfluentialSheng, B., Wing Cheng, S. K., Lau, K. K., Li, H. L., & Yiu Chan, E. L. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.06.023 · Cited by 117 · cited 1× · see citing works
“In SARS and MERS, after recovery from the infection, impairment of memory, attention, concentration, or mental processing speed were reported in more than 15% of patients at a followup period ranging between 6 weeks and 39 months (Hopkins et al., 1999; Sheng et al., 2005).”
Correlation between immune response and self-reported depression during convalescence from COVID-19
Yuan, B., Li, W., Liu, H., Cai, X., Song, S., Zhao, J., Hu, X., Li, Z., Chen, Y., Zhang, K., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.062 · Cited by 105 · cited 5× · see citing works
“No association was found between other inflammatory markers (CRP, NLR, and MLR) at baseline and three months follow-up and depression.”
InfluentialCognitive performances associate with measures of white matter integrity in bipolar disorder
Poletti, S., Bollettini, I., Mazza, E., Locatelli, C., Radaelli, D., Vai, B., Smeraldi, E., Colombo, C., & Benedetti, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.030 · Cited by 102 · cited 1× · see citing works
“We also associated this WM phenotype with neurocognitive dysfunctions (Poletti et al., 2015), an effect proportional to illness duration (Melloni et al.”
Self-citationvan der Willik, K. D., Fani, L., Rizopoulos, D., Licher, S., Fest, J., Schagen, S. B., Ikram, M. K., & Ikram, M. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1454-z · Cited by 96 · see citing works
Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men
Lu, P. H., Lee, G. J., Tishler, T. A., Meghpara, M., Thompson, P. M., & Bartzokis, G. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2012.09.006 · Cited by 92 · cited 1× · see citing works
“Consistent with the present findings, attention and information processing, verbal memory, and psychomotor coordination were among the affected domains, and given that the lifetime speed of information processing closely associates with WM microstructure in humans and in animal models (Bartzokis et al., 2012; Kochunov…”
An Introduction to Generalized Linear Models.
Campbell, M. J., & Dobson, A. J. (1991) · Biometrics · doi:10.2307/2532526 · Cited by 89 · see citing works
Armour, C., Contractor, A., Shea, T., Elhai, J. D., & Pietrzak, R. H. (2016) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000430 · Cited by 79 · cited 8× · see citing works
“To investigate changes of psychopathology over time, repeated measures ANOVAs (according to sex and psychiatric history) were performed, considering ZSDS, BDI-13, IES-R, PCL-5, STAI-Y, OCI, and WHIIRS scores at one- and three-months follow-up.”
InfluentialDietrich-Muszalska, A., & Wachowicz, B. (2017) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1155748 · Cited by 78 · cited 1× · see citing works
“Platelet activation is mediated by serotonin, dopamine, glutamate, cytokines and P-selectin, all of them plays an important role in psychiatric disorders (Dietrich-Muszalska and Wachowicz, 2017).”
Vai, B., Cazzetta, S., Ghiglino, D., Parenti, L., Saibene, G., Toti, M., Verga, C., Wykowska, A., & Benedetti, F. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.563426 · Cited by 76 · cited 2× · see citing works
“The host immune response to SARS-CoV-2 infection, the persistent psychological stress before and during infection (Korman et al., 2020; Vai et al., 2020), and a possible direct viral infections of the central nervous system represent possible mechanisms to induce neuropsychiatric sequelae (Troyer et al.”
Self-citationGrosse, L., Carvalho, L. A., Wijkhuijs, A. J. M., Bellingrath, S., Ruland, T., Ambrée, O., Alferink, J., Ehring, T., Drexhage, H. A., & Arolt, V. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.004 · Cited by 71 · cited 1× · see citing works
“Higher immune/inflammatory setpoints with higher circulating biomarkers of inflammation are observed in mood disorders in the absence of known triggering factors, and are currently investigated as underpinning pathogenetic mechanisms for depressive psychopathology (Gibney and Drexhage, 2013; Grosse et al., 2015; Polet…”
An, P., Zhou, X., Du, Y. J., Zhao, J., Song, A., Liu, H., Ma, F., & Huang, G. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200103110521 · Cited by 59 · cited 1× · see citing works
“Recently, elevated NLR was described in mild cognitive impairment, while platelet/lymphocyte ratio and SII associated with risk of dementia in the general population (An et al., 2019; van der Willik et al., 2019).”
Zhou, L., Ma, X., & Wang, W. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s216389 · Cited by 58 · see citing works
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09966-z · Cited by 55 · see citing works
Self-citationMarkers of neuroinflammation influence measures of cortical thickness in bipolar depression
Poletti, S., Leone, G., Hoogenboezem, T. A., Ghiglino, D., Vai, B., de Wit, H., Wijkhuijs, A. J. M., Locatelli, C., Colombo, C., Drexhage, H. A., et al. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.01.009 · Cited by 54 · cited 1× · see citing works
“In patients with a depressive episode in course of Major Depressive Disorder (MDD) or Bipolar Disorder (BD), we have previously reported an association of peripheral IL-8, TNF-α, CCL2, CCL4 with cortical thickness (Poletti et al., 2019); of IL-1β, IL-9, CCL5 with brain glutamate, N-acetylaspartate, and Myo-Inositol le…”
Self-citationCytokines are associated with longitudinal changes in cognitive performance among urban adults
Beydoun, M. A., Weiss, J., Obhi, H. K., Beydoun, H. A., Dore, G. A., Liang, H., Evans, M. K., & Zonderman, A. B. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.027 · Cited by 45 · cited 3× · see citing works
“In patients with a depressive episode in course of Major Depressive Disorder (MDD) or Bipolar Disorder (BD), we have previously reported an association of peripheral IL-8, TNF-α, CCL2, CCL4 with cortical thickness (Poletti et al., 2019); of IL-1β, IL-9, CCL5 with brain glutamate, N-acetylaspartate, and Myo-Inositol le…”
Melloni, E. M. T., Poletti, S., Vai, B., Bollettini, I., Colombo, C., & Benedetti, F. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.015 · Cited by 34 · cited 1× · see citing works
“, 2015), an effect proportional to illness duration (Melloni et al., 2019).”
Poletti, S., Mazza, M. G., Vai, B., Lorenzi, C., Colombo, C., & Benedetti, F. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.590095 · Cited by 25 · cited 3× · see citing works
“…by higher levels of cytokines when compared to healthy controls with consistent results in literature when considering IL-1β, IL6, IL-10, CCL2, TNF-α, and transforming growth factor-β (TGF-β) (Enache et al., 2019; Eyre et al., 2016; Howren et al., 2009; Kohler et al., 2017; Poletti et al., 2020b).”
Self-citationPsychiatry, T. L. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30102-4 · Cited by 22 · cited 1× · see citing works
“As the pandemic spread, there has been a growing recognition of mental health implications (Amsalem et al., 2020; The Lancet, 2020; * Corresponding author at: Istituto Scientifico Ospedale San Raffaele, Department of Clinical Neurosciences, San Raffaele Turro, Via Stamira d’Ancona 20, Milano, Italy.”
Virus infection as a cause of inflammation in psychiatric disorders
Bechter, K. (2013) · Modern trends in psychiatry · doi:10.1159/000343967 · Cited by 16 · cited 2× · see citing works
“Current knowledge suggests that viral infections can trigger chronic inflammation and aberrant immune responses, causing longlasting neuropsychiatric syndromes involving cognitive, affective, and behavioural symptoms, over highly variable periods after infection (from weeks to years following acute infection) (Bechter…”
InfluentialFactorial structure of the aftermath of suicide instrument
Spence, N. D., Goldney, R. D., & Moffitt, P. F. (1984) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198411)40:6 · Cited by 2 · see citing works
Flagged first, then by citations
3 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554 · see citing works
“…life compared with baseline measurements Mattioli et al., 2021 Italy Prospective Cohort Unit of Occupational Health, General University Hospital of Brescia N = 150 (120 healthcare workers cases, including 2 with previous respiratory failure requiring hospitalization) and 30 healthcare worker…”
Characterising long COVID: a living systematic review
Michelen, M., Cheng, V., Manoharan, L., Elkheir, N., Dagens, A., Hastie, C., O’Hara, M. E., Suett, J. C., Dahmash, D. T., Bugaeva, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005427 · Cited by 957 · see citing works
Nasserie, T., Hittle, M., & Goodman, S. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11417 · Cited by 702 · see citing works
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
Fernández-Castañeda, A., Lu, P., Geraghty, A. C., Song, E., Lee, M.-H., Wood, J., O’Dea, M. R., Dutton, S., Shamardani, K., Nwangwu, K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.008 · Cited by 521 · see citing works
“It is thus not surprising that the neurological sequelae of SARS-CoV-2 infection are proving to be both common and debilitating (Nasserie et al., 2021; Mazza et al., 2021; Qureshi et al., 2022; Becker et al., 2021; Tabacof et al., 2022).”
BackgroundPsychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review
Schou, T. M., Joca, S. R. L., Wegener, G., & Bay-Richter, C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.018 · Cited by 406 · see citing works
“Sleep disturbances following COVID-19 was reported in 24 studies (Al-Aly et al., 2021; Boari et al., 2021; D’Cruz et al., 2021; De Lorenzo et al., 2020; Frontera et al., 2021; Gautam et al., 2021; Gennaro et al., 2021; Graham et al., 2021; Huang et al., 2021a; Huang et al., 2021b; Iqbal et al., 2021; Lorenzo et al., 2…”
InfluentialThe neurobiology of long COVID
Monje, M., & Iwasaki, A. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.006 · Cited by 415 · see citing works
“(Mazza et al., 2021).”
Wang, S., Quan, L., Chavarro, J. E., Slopen, N. B., Kubzansky, L. D., Koenen, K. C., Kang, J. H., Weisskopf, M. G., Branch‐Elliman, W., & Roberts, A. L. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2640 · Cited by 383 · see citing works
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
Renaud‐Charest, O., Lui, L. M. W., Eskander, S., Ceban, F., Ho, R., Vincenzo, J. D. D., Rosenblat, J. D., Lee, Y. L., Subramaniapillai, M., & McIntyre, R. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.054 · Cited by 377 · see citing works
Long-term effects of COVID-19 on mental health: a systematic review
Bourmistrova, N. W., Solomon, T., Braude, P., Strawbridge, R., & Carter, B. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.031 · Cited by 369 · see citing works
“The two BDI studies, Mazza et al. (2021) and Ortelli et al. (2021) reported minimal depression, with average scores of 1.93 (95% CI = 1.34, 2.52) and 3.80 (95% CI = 2.16, 5.44) respectively.”
BackgroundResultInfluential2020 WHO guidelines on physical activity and sedentary behavior
Okely, A. D., Васильевна, К. А., Ng, J. Y. Y., & Abdeta, C. (2021) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2021.05.001 · Cited by 303 · see citing works
Montani, D., Savale, L., Noël, N., Meyrignac, O., Colle, R., Gasnier, M., Corruble, E., Beurnier, A., Jutant, E., Pham, T. O., et al. (2022) · European Respiratory Review · doi:10.1183/16000617.0185-2021 · Cited by 266 · see citing works
“In the other study, the prevalence of post-traumatic stress disorder was 30% at 1 – 3 months after a severe acute episode [55].”
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mazza, M. G., Palladini, M., Poletti, S., & Benedetti, F. (2022) · CNS Drugs · doi:10.1007/s40263-022-00931-3 · Cited by 233 · see citing works
“Interestingly, two studies found that reducing inflammatory markers over time predicted improvement of depressive symptoms at follow-up [10, 98].”
BackgroundInfluentialSelf-citationCOVID-19 associated cognitive impairment: A systematic review
Tavares-Júnior, J. W. L., de Souza, A. C. C., Borges, J. W. P., Oliveira, D. N., Neto, J. I. S., Sobreira-Neto, M. A., & Braga‐Neto, P. (2022) · Cortex · doi:10.1016/j.cortex.2022.04.006 · Cited by 179 · see citing works
Seighali, N., Abdollahi, A., Shafiee, A., Amini, M. J., Athar, M. M. T., Safari, O., Faghfouri, P., Eskandari, A., Rostaii, O., Salehi, A. H., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-023-05481-6 · Cited by 189 · see citing works
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study
Cecchetti, G., Agosta, F., Canu, E., Basaia, S., Barbieri, A., Cardamone, R., Bernasconi, M. P., Castelnovo, V., Cividini, C., Cursi, M., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11047-5 · Cited by 163 · see citing works
Self-citationLipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation
Yin, R., Zhang, K., Li, Y., Tang, Z., Zheng, R., Ma, Y., Chen, Z., Lei, N., Xiong, L., Guo, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1181973 · Cited by 160 · see citing works
Psychiatric and neurological complications of long COVID
Zawilska, J. B., & Kuczyńska, K. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.045 · Cited by 146 · see citing works
Neuropsychological deficits in patients with cognitive complaints after COVID‐19
García‐Sánchez, C., Calabria, M., Grunden, N., Pons, C., Arroyo, J. A., Gómez‐Ansón, B., Lleó, A., Alcolea, D. A., Belvís, R., Morollón, N., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2508 · Cited by 149 · see citing works
“…long-term effects, Ferrucci et al. (2021) reported evidence of long-term memory deficits in COVID-19 patients 5 months after hospitalization and Mazza et al. (2021) found that half of their COVID19 patient sample demonstrated executive function deficits and 30% of them showed impairments in…”
BackgroundInterleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
Kappelmann, N., Dantzer, R., & Khandaker, G. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105295 · Cited by 138 · see citing works
Systematic Review of the Prevalence of Long COVID
Woodrow, M., Carey, C., Ziauddeen, N., Thomas, R., Akrami, A., Lutje, V., Greenwood, D. C., & Alwan, N. A. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad233 · Cited by 146 · see citing works
Li, J., Zhou, Y., Ma, J., Zhang, Q., Shao, J., Liang, S., Yu, Y., Li, W., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01640-z · Cited by 139 · see citing works
Poletti, S., Palladini, M., Mazza, M. G., LORENZO, R. D., Bollettini, I., Sara, B., Bravi, B., Ceciclio, B., Stefania, C., Valentina, C., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01346-9 · Cited by 136 · see citing works
Self-citationBenedetti, F., Palladini, M., Paolini, M., Melloni, E. M. T., Vai, B., LORENZO, R. D., Furlan, R., Rovere, P. Q., Falini, A., & Mazza, M. G. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100387 · Cited by 127 · see citing works
“This is an open access ar post-traumatic distress that persist for months after virus clearance and discharge from the hospital, and leads to the need for psychiatric intervention and psychotropic medication (Taquet et al., 2020, 2021; Mazza et al., 2021).”
InfluentialSelf-citationCOVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction
Chen, Y., Yang, W., Chen, F., & Cui, L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02579-8 · Cited by 124 · see citing works
Visco, V., Vitale, C., Rispoli, A., Izzo, C., Virtuoso, N., Ferruzzi, G. J., Santopietro, M., Melfi, A., Rusciano, M. R., Maglio, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030524 · Cited by 118 · see citing works
Thye, A. Y.-K., Law, J. W., Tan, L. T., Pusparajah, P., Ser, H., Thurairajasingam, S., Letchumanan, V., & Lee, L. (2022) · Biology · doi:10.3390/biology11010061 · Cited by 115 · see citing works
Obsessive–Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review
Guzick, A. G., Candelari, A. E., Wiese, A. D., Schneider, S. C., Goodman, W. K., & Storch, E. A. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01284-2 · Cited by 109 · see citing works
Long COVID and neuropsychiatric manifestations (Review)
Efstathiou, V., Stefanou, M., Demetriou, M., Siafakas, N., Makris, M. P., Tsivgoulis, G. K., Zoumpourlis, V., Kympouropoulos, S. P., Tsoporis, J. N., Spandidos, D. A., et al. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11290 · Cited by 113 · see citing works
“Of note, Mazza et al (39), in 2020, assessed 402 COVID‑19 survivors at 1 month following treatment at the hospital emer‑ gency department, using self‑rated psychometric instruments, and found that overall, 56% scored in the pathological range in at least one clinical dimension [i.e., including depression, anxiety, pos…”
BackgroundResultInfluentialPersistent white matter changes in recovered COVID-19 patients at the 1-year follow-up
Huang, S., Zhou, Z., Yang, D., Zhao, W., Zeng, M., Xie, X., Du, Y., Jiang, Y., Zhou, X., Yang, W., et al. (2021) · Brain · doi:10.1093/brain/awab435 · Cited by 101 · see citing works
“lymphocytes).(14) Baseline clinical characteristics and inflammatory markers were used for further analysis in this study.”
MethodCellular and molecular biomarkers of long COVID: a scoping review
Espín, E., Yang, C., Shannon, C. P., Assadian, S., He, D. X., & Tebbutt, S. J. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104552 · Cited by 105 · see citing works
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
Su, S., Zhao, Y., Zeng, N., Liu, X., Zheng, Y., Sun, J., Zhong, Y., Wu, S., Ni, S., Gong, Y.-M., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02171-3 · Cited by 105 · see citing works
“Another study showed that a baseline systemic immune-in fl ammation index (SII) based on peripheral lymphocyte, neutrophil and platelet counts predicted depressive symptoms and cognitive impairment at three-month follow-up [136].”
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works
One-year mental health outcomes in a cohort of COVID-19 survivors
Mazza, M. G., Palladini, M., LORENZO, R. D., Bravi, B., Poletti, S., Furlan, R., Ciceri, F., Vai, B., Bollettini, I., Melloni, E. M. T., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.031 · Cited by 96 · see citing works
“Psychiatric long-term complaints affected the quality of life, associated with cognitive impairments, and fatigue syndromes (Manning et al., 2021; Mazza et al., 2021).”
Self-citationCognitive impairment in people with previous COVID-19 infection: A scoping review
Bertuccelli, M., Ciringione, L., Rubega, M., Bisiacchi, P. S., Masiero, S., & Felice, A. D. (2022) · Cortex · doi:10.1016/j.cortex.2022.06.002 · Cited by 99 · see citing works
“The single study evaluating the presence of obsessivecompulsive disorders due to COVID-19 failed to find significant results (OCI score: 14.04 ± 11.71 for Mazza et al., 2021).”
InfluentialAjčević, M., Iscra, K., Furlanis, G., Michelutti, M., Miladinović, A., Stella, A. B., Ukmar, M., Cova, M. A., Accardo, A., & Manganotti, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-32275-3 · Cited by 99 · see citing works
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Silva, N. M. L. E., Barros‐Aragão, F. G. Q., Felice, F. G. D., & Ferreira, S. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109023 · Cited by 93 · see citing works
Oh, H. Y., Marinovich, C., Rajkumar, R. P., Besecker, M., Zhou, S., Jacob, L., Koyanagi, A., & Smith, L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.121 · Cited by 91 · see citing works
“In support of this possibility, a recent study of COVID-19 survivors (N = 226) found that 35.8% had persistent symptoms of psychological distress, particularly depression, and these symptoms were positively correlated with a baseline measure of systemic inflammation (Mazza et al., 2021).”
InfluentialFernández-Castañeda, A., Lu, P., Geraghty, A. C., Song, E., Lee, M.-H., Wood, J., Yalçın, B., Taylor, K. R., Dutton, S., Acosta-Alvarez, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.475453 · Cited by 101 · see citing works
“(Mazza et al., 2021).”
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
Henneghan, A. M., Lewis, K., Gill, E. R., & Kesler, S. R. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.770459 · Cited by 83 · see citing works
Larger gray matter volumes in neuropsychiatric long-COVID syndrome
Besteher, B., Machnik, M., Troll, M., Toepffer, A., Zerekidze, A., Rocktäschel, T., Heller, C., Kikinis, Z., Brodoehl, S., Finke, K., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114836 · Cited by 81 · see citing works
“…to controls at the day of scanning all participants were rated for symptoms of depression with Montgomery-Asberg Depression Rating Scale (MADRS, (Montgomery et al., 1985) and completed the State-Trait-Anxiety Inventory (STAI, (Spielberger and Vagg, 1984) as a self-rating assessment for symptoms…”
Neurocognitive Impairment in Long COVID: A Systematic Review
Panagea, E., Messinis, L., Petri, M. C., Liampas, I., Anyfantis, E., Nasios, G., Patrikelis, P., & Kosmidis, M. H. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae042 · Cited by 85 · see citing works
Miskowiak, K. W., Pedersen, J. K., Gunnarsson, D. V., Roikjer, T. K., Podlekareva, D. N., Hansen, H., Dall, C. H., & Johnsen, S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.122 · Cited by 79 · see citing works
“2022), other studies found high frequencies of impairment across executive function, attention and memory (Bungenberg et al. 2022; CostasCarrera et al. 2022; Crivelli et al. 2022; Jaywant et al. 2021; Krishnan et al. 2022; Lopez-Leon et al. 2021; Mazza et al. 2021; Miskowiak et al. 2021; Miskowiak et al. 2022).”
Hellgren, L., Thornberg, U. B., Samuelsson, K., Levi, R., Divanoglou, A., & Blystad, I. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055164 · Cited by 77 · see citing works
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.09.009 · Cited by 75 · see citing works
Self-citationBridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19
Frontera, J. A., & Simon, N. M. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.1616 · Cited by 72 · see citing works
Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue
Mazza, M. G., Palladini, M., Villa, G., LORENZO, R. D., Rovere, P. Q., & Benedetti, F. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.08.008 · Cited by 69 · see citing works
“…apart from fatigue, depressive symptoms have also been associated with neurocognitive functioning (Gouraud et al., 2021; Mattioli et al., 2021; Mazza et al., 2021b; Poletti et al., 2021) and quality of life (Babicki et al., 2021; Poletti et al., 2021) in COVID-19 survivors, the reported…”
Self-citationLombardo, M. D. M., Foppiani, A., Peretti, G. M., Mangiavini, L., Battezzati, A., Bertoli, S., Boneschi, F. M., & Zuccotti, G. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab384 · Cited by 68 · see citing works
Kadier, K., Dilixiati, D., Ainiwaer, A., Liu, X., Lu, J.-D., Liu, P., Ainiwan, M., Yesitayi, G., Ma, X., & Ma, Y.-T. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05286-7 · Cited by 70 · see citing works
“Investigations into the psychopathological status of survivors of COVID-19 have revealed that long-standing systemic inflammatory status can be reflected by inflammatory parameters such as SII and is closely related to anxiety and somatization and sleep disorders [16, 17].”
BackgroundMiskowiak, K. W., Fugledalen, L., Jespersen, A. E., Sattler, S. M., Podlekareva, D. N., Rungby, J., Porsberg, C., & Johnsen, S. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.004 · Cited by 62 · see citing works
“While the functional implication of cognitive impairments after COVID-19 are evident, the neurobiological origins of these long-term impairments remain unclear and are likely multifactorial (Baldini et al., 2021; Mazza et al., 2021; Moonis et al., 2020; Scardua Silva et al., 2021).”
BackgroundBrain fog as a Long-term Sequela of COVID-19
Nouraeinejad, A. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01352-5 · Cited by 69 · see citing works
“from 3 COVID-19-designated hospitals] [26], a cohort study [investigated the frequency, pattern and severity of cognitive impairments 3–4 months after COVID-19 hospital discharge] [20], a cohort study [compared critically ill and noncritically ill patients categorized according to the presence of acute respiratory dis…”
Paolini, M., Palladini, M., Mazza, M. G., Colombo, F., Vai, B., Rovere, P. Q., Falini, A., Poletti, S., & Benedetti, F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.002 · Cited by 61 · see citing works
“A key concern is the long-lasting cognitive consequences of the infection (10-12), representing a critical and debilitating feature of the so-called Post-acute COVID-19 syndrome (PACS) (2, 13).”
BackgroundSelf-citationObsessive-compulsive symptoms and the Covid-19 pandemic: A rapid scoping review
Grant, J. E., Drummond, L. M., Nicholson, T. R., Fagan, H. A., Baldwin, D. S., Fineberg, N. A., & Chamberlain, S. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.039 · Cited by 57 · see citing works
“In a very recent study, diagnostic information and psychiatric symptom measures (including for OCD) were collected from 226 Covid-19 pneumonia survivors (Mazza et al., 2021).”
MethodCostas‐Carrera, A., Sánchez‐Rodríguez, M. M., Cañizares, S., Ojeda, A., Martín‐Villalba, I., Primé‐Tous, M., Rodríguez-Rey, A., Segú, X., Valdesoiro‐Pulido, F., Borràs, R., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100425 · Cited by 59 · see citing works
Singewald, N., Sartori, S. B., Reif, A., & Holmes, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109418 · Cited by 61 · see citing works
Zhou, Z., Luo, H., Liu, J., Du, Y., Zhao, W., Zhou, X.-L., Zeng, M., Yang, D., Xie, X., Huang, S., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327361 · Cited by 53 · see citing works
“Reviewing what has been examined thus far, psychopathological sequelae can occur during the acute or subacute infection period in patients with COVID-19 and have been reported to be significantly related to inflammatory biomarkers collected during hospitalization (Mazza et al., 2020, 2021).”
BackgroundDynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study
Huang, S., Zhou, X., Zhao, W., Du, Y., Yang, D., Huang, Y., Chen, Y., Zhang, H., Yang, G., Liu, J., et al. (2023) · Theranostics · doi:10.7150/thno.79902 · Cited by 53 · see citing works
Cognitive impairment after long COVID-19: current evidence and perspectives
Li, Z., Zhang, Z., Zhang, Z., Wang, Z., & Li, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1239182 · Cited by 58 · see citing works
Risk factors for psychiatric symptoms in patients with long COVID: A systematic review
Zakia, H., Pradana, K., & Iskandar, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284075 · Cited by 53 · see citing works
The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
Pyne, J. D., & Brickman, A. M. (2021) · Neurodegenerative Diseases · doi:10.1159/000518581 · Cited by 48 · see citing works
He, D., Yuan, M., Dang, W., Bai, L., Yang, R., Wang, J., Ma, Y., Liu, B., Liu, S., Zhang, S., et al. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103409 · Cited by 50 · see citing works
“A pervious study showed the systemic inflammation was a predict factor to the neurocognitive performance (Mazza et al., 2021).”
Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19
Dąbrowska, E., Galińska-Skok, B., & Waszkiewicz, N. (2021) · Life · doi:10.3390/life11101056 · Cited by 47 · see citing works
“Based on the current medical knowledge, it is suggested that a history of a SARS-CoV-2 infection may have a significant impact on the reduction in neurocognitive functions [19,125,174,194].”
BackgroundInfluentialPoletti, S., Zanardi, R., Mandelli, A., Aggio, V., Finardi, A., Lorenzi, C., Borsellino, G., Carminati, M., Manfredi, E., Tomasi, E., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.019 · Cited by 50 · see citing works
Self-citationKulaga, S. S., & Miller, C. W. T. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.008 · Cited by 51 · see citing works
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature
Perrottelli, A., Sansone, N., Giordano, G. M., Caporusso, E., Giuliani, L., Melillo, A., Pezzella, P., Bucci, P., Mucci, A., & Galderisi, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12122070 · Cited by 46 · see citing works
“Seven of the studies included more than 50% of hospitalized patients [9,63,80,84,88,92,98].”
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
McIntyre, R. S., Phan, L., Kwan, A. T. H., Mansur, R. B., Rosenblat, J. D., Guo, Z., Le, G. H., Lui, L. M. W., Teopiz, K. M., Ceban, F., et al. (2023) · Brain · doi:10.1093/brain/awad377 · Cited by 45 · see citing works
Borsini, A., Merrick, B., Edgeworth, J., Mandal, G., Srivastava, D. P., Vernon, A. C., Nebbia, G., Thuret, S., & Pariante, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01741-1 · Cited by 44 · see citing works
Nowakowski, S., Kokonda, M., Sultana, R., Duong, B. B., Nagy, S. E., Zaidan, M., Baig, M. M., Grigg, B. V., Seashore, J., & Deer, R. (2022) · Brain Sciences · doi:10.3390/brainsci12050586 · Cited by 41 · see citing works
“Initial data suggest that sleep disorders may improve with increased time since recovery, but whether sleep quality returns to baseline has yet to be seen [9,10].”
BackgroundDale, L. P., Cuffe, S. P., Kołacz, J., Leon, K. G., Biernacki, N. B., Bhullar, A., Nix, E. J., & Porges, S. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.830926 · Cited by 44 · see citing works
Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien
Rabady, S., Altenberger, J., Brose, M., Denk‐Linnert, D., Fertl, E., Götzinger, F., Pellı́n, M. D. L. C., Hofbaur, B., Hoffmann, K., Hoffmann-Dorninger, R., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01974-0 · Cited by 43 · see citing works
Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review
Biagianti, B., Di Liberto, A., Nicolò Edoardo, A., Lisi, I., Nobilia, L., de Ferrabonc, G. D., Zanier, E. R., Stocchetti, N., & Brambilla, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909661 · Cited by 41 · see citing works
Moura, A. E. F., Oliveira, D. N., Torres, D., Tavares-Júnior, J. W. L., Nóbrega, P. R., Braga‐Neto, P., & Sobreira-Neto, M. A. (2022) · BMC Neurology · doi:10.1186/s12883-022-02940-7 · Cited by 45 · see citing works
“The relationship between ES and depression is probably bidirectional, with poor sleep quality negatively affecting mood state and poor sleep quality and ES as a possible result of depression [12, 32].”
BackgroundPrevalence of depression in SARS-CoV-2 infected patients: An umbrella review of meta-analyses
Mazza, M. G., Palladini, M., Villa, G., Agnoletto, E., Harrington, Y. A., Vai, B., & Benedetti, F. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.12.002 · Cited by 44 · see citing works
“Sparse longitudinal studies have directly investigated the trajectory of depression after SARS-CoV-2 infection, reporting inconsistent findings suggesting both persistent [8,9,43] and decreasing [44] depressive psychopathology over follow-ups.”
BackgroundSelf-citationNiu, Y., Lv, Z.-H., Sun, C., Wen, Y.-Y., Tao, T.-Y., Qian, D., Tao, F.-P., & Yu, J.-H. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1112383 · Cited by 39 · see citing works
Zhou, S., Wei, T., Liu, X., Liu, Y., Song, W., Que, X., Xing, Y., Wang, Z., & Tang, Y. (2023) · BMC Medicine · doi:10.1186/s12916-023-02952-1 · Cited by 42 · see citing works
Hassan, N. M., Salim, H. S., Amaran, S., Yunus, N. I., Yusof, N. A., Daud, N., & Fry, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282538 · Cited by 42 · see citing works
Cognitive domains affected post‐COVID ‐19; a systematic review and meta‐analysis
Fanshawe, J. B., Sargent, B., Badenoch, J., Saini, A., Watson, C. J., Pokrovskaya, A., Aniwattanapong, D., Conti, I., Nye, C., Burchill, E., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16181 · Cited by 48 · see citing works
Lifestyle Adjustments in Long-COVID Management: Potential Benefits of Plant-Based Diets
Storz, M. A. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00369-x · Cited by 42 · see citing works
Wang, Q., Yan, K., Li, K.-D., Gao, L., Wang, X., Liu, H., Zhang, Z., Li, K., & Cui, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153735 · Cited by 36 · see citing works
Cui, S., Li, J., Liu, Y., Yao, G., Wu, Y., Liu, Z., Sun, L., Sun, L., & Liu, H. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1159889 · Cited by 39 · see citing works
Mental health outcomes of adults hospitalized for COVID-19: A systematic review
Veazie, S., Lafavor, B., Vela, K., Young, S., Sayer, N. A., Carlson, K. F., & O'Neil, M. E. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100312 · Cited by 35 · see citing works
Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management?
Hüfner, K., Tymoszuk, P., Ausserhofer, D., Sahanic, S., Pizzini, A., Rass, V., Gálffy, M., Boehm, A., Kurz, K., Sonnweber, T., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.792881 · Cited by 32 · see citing works
Damiano, R. F., Rocca, C. C. D. A., Serafim, A. D. P., Loftis, J. M., Talib, L. L., Pan, P. M., Cunha‐Neto, E., Kalil, J. E., de Castro, G. S., Seelaender, M. C. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1174020 · Cited by 35 · see citing works
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Review
Popa, E., Popa, A. E., Poroch, M., Poroch, V., Ungureanu, M. I., Slănină, A. M., Bacușcă, A. I., & Coman, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115102 · Cited by 38 · see citing works
“Astrocytic and axonal injury is reflected by increased levels of GFAP [33,48,58,74,82] and NFL [33,39,47,48], while FKBP5 and LGALS3 are linked to tau phosphorylation and neurotoxicity [48,51].”
Luca, R. D., Bonanno, M., & Calabrò, R. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216554 · Cited by 36 · see citing works
Kirchberger, I., Peilstöcker, D., Warm, T. D., Linseisen, J., Hyhlik-Dürr, A., Meisinger, C., & Goßlau, Y. (2023) · Viruses · doi:10.3390/v15010256 · Cited by 31 · see citing works
Central nervous system outcomes of COVID-19
Doyle, M. F. (2021) · Translational research · doi:10.1016/j.trsl.2021.09.002 · Cited by 30 · see citing works
Poletti, S., Paolini, M., Mazza, M. G., Palladini, M., Furlan, R., Rovere, P. Q., & Benedetti, F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.06.008 · Cited by 34 · see citing works
Self-citationSu, W., Ju, J., Gu, M., Wang, X., Liu, S., Yu, J., & Mu, D.-L. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02786-x · Cited by 33 · see citing works
Neuroimmune Pathophysiology of Long COVID
Moen, J. K., Baker, C. A., & Iwasaki, A. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13855 · Cited by 25 · see citing works
“238 – 241 Notably, measurements of anxiety and depression can be confounded by the presence of comorbid conditions like dysautonomia in Long COVID, which have overlapping symptoms that can arti fi cially in fl ate scores in common self-reported symptom scales and lead to misdiagnosis.”
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 28 · see citing works
“Psychiatric manifestations and long- term post- infectious manifestations including anxiety and fatigue are also increasingly recognized as possible infectious complications (Carfi et al., 2020; Mazza et al., 2021; Halpin et al., 2020; Varatharaj et al., 2020).”
BackgroundHuarcaya-Victoria, J., Barreto, J., Aire, L., Podestà, Á., Caqui, M., Guija-Igreda, R., Castillo, C., & Alarcon-Ruiz, C. A. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-021-00659-z · Cited by 33 · see citing works
Bower, J., Radin, A., & Kuhlman, K. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104104 · Cited by 30 · see citing works
Brown, L. A., Ballentine, E., Zhu, Y., McGinley, E. L., Pezzin, L. E., & Abramoff, B. A. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100460 · Cited by 30 · see citing works
Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19
Shabani, Z., Liu, J., & Su, H. (2023) · Biology · doi:10.3390/biology12081106 · Cited by 40 · see citing works
Complex association between post-COVID-19 condition and anxiety and depression symptoms
Tebeka, S., Carcaillon‐Bentata, L., Decio, V., Alleaume, C., Beltzer, N., Gallay, A., Lemogne, C., Pignon, B., Makovski, T. T., & Coste, J. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2473 · Cited by 28 · see citing works
“Indeed, female sex and chronic conditions are both well-established risk factors for PCC [40 – 45].”
BackgroundPalladini, M., Bravi, B., Colombo, F., Caselani, E., Pasquasio, C. D., D'Orsi, G., Rovere, P. Q., Poletti, S., Benedetti, F., & Mazza, M. G. (2022) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2022.2075016 · Cited by 28 · see citing works
“In this context, our precedent investigation provides early evidence about the detrimental impact of depressive symptoms on middle-term cognitive performances in a longitudinal cohort of covid-19 survivors (Mazza et al., 2021).”
BackgroundMethodResultInfluentialSelf-citationGonzalo Labarca, T., Henríquez‐Beltrán, M., Lamperti, L., Nova‐Lamperti, E., Sanhueza, S. A., Cabrera, C., Quiroga, R. A., Antilef, B., Ormazábal, V., Zuñiga, F. A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.884218 · Cited by 29 · see citing works
The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
Liu, N., Jiang, X., & Li, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1129640 · Cited by 24 · see citing works
“An observational clinical study reported long-term cognitive abnormalities in nearly 50% of COVID-19 survivors (Mazza et al., 2021).”
BackgroundNavigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response
Mohan, A., Iyer, V. A., Kumar, D., Batra, L., & Dahiya, P. (2023) · Life · doi:10.3390/life13112121 · Cited by 30 · see citing works
- Authors
- Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Mazza, Mario Gennaro
- ORCID
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 94
- Pages
- 138-147
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC7903920
- OpenAlex
- W3129342553
- Semantic Scholar
- 2c34e539a6d09867be7208e71f8a551c08e53ca0
- Cited by
- 513
- References
- 78
- Citations by year
- 2026: 23 · 2025: 66 · 2024: 109 · 2023: 148 · 2022: 115 · 2021: 50
- FWCI
- 50.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, post-COVID-19 mental health, dysthymia, neurocognitive impairment, systemic inflammation, inflammatory markers, systemic immune-inflammation index, executive function, psychomotor coordination, verbal memory, verbal fluency, processing speed, long COVID
- MeSH terms
- COVID-19, SARS-CoV-2, Mental Disorders, Child, Preschool, Cognition Disorders, Follow-Up Studies, Humans, Male, Neuropsychological Tests, Prospective Studies, Biomarkers, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review